CD8⁺ T cells are the immune system's frontline warriors, charged with detecting and eliminating cancer cells. But in the ...

The discovery may explain why cutting edge CAR T-cell therapy has managed to revolutionized treatment for blood cancer but ...

The story behind the development of immune checkpoint inhibitors, fulfilling the promise of cancer immunotherapy ...

By Dennis Thompson HealthDay ReporterMONDAY, July 7, 2025 (HealthDay News) — Radiation therapy to treat cancer might be a ...

The Korea Research Institute of Standards and Science (KRISS, President Lee Ho Seong) has successfully developed a ...

Cancer-fighting T-cells, the immune system's primary enforcers, are scarce in the rare kidney cancer called chromophobe renal ...

Immunologists at UNIGE have revealed a previously unknown anti-tumor role of CD4 T lymphocytes, marking a breakthrough that ...

Survival rates in cancer patients on immune checkpoint inhibitors depended on their insurance coverage, new study found.

Scientists at UC Davis discovered a small genetic difference that could explain why humans are more prone to certain cancers ...

Access to and affordability of immune checkpoint inhibitors, which can be lifesaving if patients receive them on time and ...

I’ve survived rare blood cancer for 15 years, but the lasting side effects have taken a toll — even so, I still find purpose, ...

Corticosteroids, a commonly prescribed medication to alleviate cancer-related symptoms for non-small cell lung cancer ...